Haleon Organic Growth Falls to 3%, Shares Drop 3.4% on Target Miss
Haleon’s organic revenue growth for the year reached just 3%, missing its medium-term target, as a mild winter and a delayed flu season weighed on respiratory-health products. Shares fell 3.4% after the company’s fourth-quarter growth also slowed below expectations.
1. Organic Growth Misses Target
Haleon reported full-year organic revenue growth of 3%, falling short of its own medium-term target and marking a slowdown from earlier in the fiscal year.
2. Drivers of Slowdown
A mild winter delayed flu season, reducing demand for respiratory-health products, while cautious American consumer spending further dampened fourth-quarter organic gains.
3. Market Reaction
Shares declined 3.4% following the announcement, as investors weighed the growth miss and potential margin pressure from weaker product sales.
Related News
MWC
Micware Co. Soars 51.5% in IPO Debut, Raises $22.8M
MWC•
MA
Chargebacks911 Partners with acceptcards to Reduce Chargebacks as UK Card Use Tops £1 Trn
MA•
NVDL
GraniteShares 2x Daily Nvidia ETF Gains 172%, Tops $4 Billion AUM
NVDL•
WMT
Walmart Set for Q1 EPS of $0.66 on $175B Revenue; Value Outlook Tempered
WMT•
T
AT&T Commits $19 B to California Fiber and 1,200 New Cell Sites by 2030
T•
Sources
FRFF